CLINICAL AND EPIDEMIOLOGICAL STUDY OF MULTIPLE SCLEROSIS IN SVOGE AND TROYAN

被引:0
作者
Nikolova, Antonia [1 ]
Milanov, Ivan [2 ]
Kmetska, Ksenia [2 ]
机构
[1] Med Univ Sofia, Med Fac, Dept Neurol, 15 Ivan Evstratiev Geshov Blvd, Sofia 1431, Bulgaria
[2] Univ Multiprofile Hosp Act Treatment Neurol & Psyc, Dept Multiple Sclerosis, 1 Lyuben Rusev St, Sofia 1113, Bulgaria
来源
COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES | 2024年 / 77卷 / 10期
关键词
epidemiology; multiple sclerosis; prevalence; incidence;
D O I
10.7546/CRABS.2024.10.17
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Multiple sclerosis is a chronic inflammatory, autoimmune, demyelinating and neurodegenerative disease of the central nervous system. It is characterized by various symptoms depending on the area affected - brain, spinal cord or optic nerves. Multiple sclerosis typically presents at age 20-40 years and affects women more often than men. It is the most frequent nontraumatic disease causing neurologic deficit among young people. According to the 3rd edition of Atlas of MS, published by The Multiple Sclerosis International Federation in 2020, there are 2.8 million people living with the disease around the world. The last study on the epidemiology of multiple sclerosis in Bulgaria was published in 1999. It estimated prevalence of 44.5/100000 and incidence 1.03/100000. We present an epidemiological study conducted between January 2016 and December 2020 in two small areas in Bulgaria with homogenous and stable population - Svoge and Troyan. The estimated prevalence of multiple sclerosis in Troyan was 116.5/100 000 with incidence of 28.2/100 000. The prevalence and incidence of multiple sclerosis in Svoge were 117.7/100000 and 24.5/100000, respectively. The reason for the higher prevalence and incidence rates in our study may be explained by the better diagnosis of the disease according to well defined diagnostic criteria, the longer survival of the affected individuals and the availability of various disease modifying therapies.
引用
收藏
页码:1560 / 1566
页数:7
相关论文
共 16 条
  • [1] [Anonymous], 2020, Atlas of MS, V3rd
  • [2] Multiple sclerosis - a review
    Dobson, R.
    Giovannoni, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (01) : 27 - 40
  • [3] GEORGIEV D., 1994, Multiple Sclerosis in Europe: An Epidemiological Update, P322
  • [4] KALAFATOVA O. I., 1983, Doctoral thesis
  • [5] EPIDEMIOLOGY OF MULTIPLE-SCLEROSIS IN BULGARIA
    KALAFATOVA, OI
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1987, 75 (03): : 186 - 189
  • [6] Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the Northern hemisphere?
    Koch-Henriksen, Nils
    Sorensen, Per Soelberg
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 311 (1-2) : 58 - 63
  • [7] KOINOV R., 1977, 11 WORLD C NEUR AMST
  • [8] Epidemiology of multiple sclerosis
    Leray, E.
    Moreau, T.
    Fromont, A.
    Edan, G.
    [J]. REVUE NEUROLOGIQUE, 2016, 172 (01) : 3 - 13
  • [9] New Multiple Sclerosis Phenotypic Classification
    Lublin, Fred D.
    [J]. EUROPEAN NEUROLOGY, 2014, 72 : 1 - 5
  • [10] MARKOV G., 1974, Scripta Scientifica Medica (Varna), V11, P77